Drug
Cabozantinib Once A Day
Cabozantinib Once A Day: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cabozantinib 40 MG oral once a day NCT04230954 | Phase 2 | Cervical Cancer |
Latest
No recent events.
Follow Cabozantinib Once A Day on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.